#AstraZeneca

Emilia C Skirmuntt 🦇🧬🦠

ESkirmuntt

Let’s talk about vaccines and dosing again (another thread;) )There is a lot of talk at the moment about dosing and delays. First, it was the UK who decided to

Mac n’ Chise 🧬🧫🦠

sailorrooscout

The importance of T-cell immunity!A recent study has found that after one dose of Pfizer’s vaccine, patients had a strong T-cell response, and a boosted antibody response after their second

Mark Toshner

mark_toshner

Quick tweetorial on why the design of the different vaccine studies is important. I'm also going to talk about how reporting has coloured the debate. My disclosures- Minor investigator on

Alastair McAlpine, MD

AlastairMcA30

So as per @sindivanzyl’s request, this is a continuation from yesterday’s thread on our immune systems.This will focus on vaccines, and how they work. We’ll look at how Covid19 vaccines

Bob Wachter

Bob_Wachter

1/ Covid (@UCSF) Chronicles, Day 282Holiday greetings – hope you’re getting a little R&R. I’m on clinical svc @ucsfhospitals – welcome break from a Life of Zoom, leavened by a

Dr Sumaiya Shaikh

Neurophysik

COVAXIN Efficacy: A thread...n0 Q1: Is there a method to hypothesise the efficacy of COVAXIN when no data has been released?Q2: How is this efficacy enhanced & measured? Q3: Why

Albert Pinto

70sBachchan

Hard for most poor countries to use Pfizer's or Moderna's mRNA vaccine that need a cold-chain to keep stable. Rich countries take complex logistical energy-intensive refrigeration for granted. https://www.wsj.com/articles/vaccines-a

Hilda Bastian, PhD

hildabast

Phase 3 trial for Sputnik V results landed!To keep in mind: randomized 3 to 1 (not half in vax group, half placebo). It's a pair of vaccines, 1 shot of

Kai Kupferschmidt

kakape

Just listened to a fascinating webinar by @ShabirMadh presenting the results from Novavax trial in South Africa and UK.So will turn this into a brief thread to give some context

Mac n’ Chise 🧬🧫🦠

sailorrooscout

Good mRNA vaccine news this morning! Ben Osborn, the UK head of Pfizer, said they do not expect to have to change their vaccine to handle SARS-CoV-2 variants B.1.1.17 and

Justin Ling

Justin_Ling

This is such a yarn. This facility has been in the works since the Summer, and is still *months* away from being completed, let alone operational. The previous plan involved

Ashley Holub, PhD

ashtroid22

Come for the Bernie memes, stay for the science. Now that I have you all here, lets talk about the differences between Emergency Use Authorization (EUA) and Approval. By now,

Alison Blunt

AlisonBlunt

1. Toxicologist Hockertz: Approval of Coronavaccine is "intentional gross bodily injury” 16.12.2020 https://snanews.de/20201216/toxikologe-corona-impfstoff-187459.html unofficial translation follows...'One of the most renowned cr

Alex Good

goodalexander

With Yolo-ers on Spring Break, call options are getting cheaper. Some friends and I made a tool https://www.dankoptions.com to find the "Dankest" call options - those that are cheapest given

Scott Beasley

SkyScottBeasley

NEW: One dose of AstraZeneca/Oxford vaccine offers 76% protection after day 22 post vaccination - and offers sustained protection through a 3 month period until second dose New analysis by

Prof. Akiko Iwasaki

VirusesImmunity

How well do various vaccines reduce severe COVID disease & death? Awesome @YaleMed students, @dariusdariusdar, @ChaneyKalinich, @Larson_HaleighT & Caroline Valdez put together summary tables from vaccine trials. Remarkable ability o

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.